Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.
Healey JS, Eikelboom J, Yang S, Themeles E, Connolly SJ, Yusuf S, Douketis J, Wallentin L, Oldgren J, Heidbuchel H, Avezum A, Reilly P, Ezekowitz M. Healey JS, et al. Among authors: douketis j. Circulation. 2013 Mar 19;127(11):e506. doi: 10.1161/circulationaha.112.154732. Circulation. 2013. PMID: 23646374 No abstract available.
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, Themeles E, Heidbuchel H, Avezum A, Reilly P, Connolly SJ, Yusuf S, Ezekowitz M; RE-LY Investigators. Healey JS, et al. Among authors: douketis j. Circulation. 2012 Jul 17;126(3):343-8. doi: 10.1161/CIRCULATIONAHA.111.090464. Epub 2012 Jun 14. Circulation. 2012. PMID: 22700854 Clinical Trial.
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
Douketis JD, Healey JS, Brueckmann M, Eikelboom JW, Ezekowitz MD, Fraessdorf M, Noack H, Oldgren J, Reilly P, Spyropoulos AC, Wallentin L, Connolly SJ. Douketis JD, et al. Thromb Haemost. 2015 Mar;113(3):625-32. doi: 10.1160/TH14-04-0305. Epub 2014 Dec 4. Thromb Haemost. 2015. PMID: 25472710
Response.
Douketis J, Eikelboom J, Liew A, Bell AD. Douketis J, et al. Can Fam Physician. 2015 Jan;61(1):24-5. Can Fam Physician. 2015. PMID: 25609517 Free PMC article. No abstract available.
How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society.
Gladstone DJ, Geerts WH, Douketis J, Ivers N, Healey JS, Leblanc K. Gladstone DJ, et al. Among authors: douketis j. Ann Intern Med. 2015 Sep 1;163(5):382-5. doi: 10.7326/M15-0143. Ann Intern Med. 2015. PMID: 26121536 No abstract available.
408 results